This study investigated the effect of muscarinic M 1 and M 2 receptor antagonists on [MET10]). The EC 95 of rocuronium was significantly lower in the PZP10 group than in the control group. In the PZP10 group, the TOF ratios at 50% and first twitch tension depression were significantly lower than those in the control group (P=.02). During tetanic stimulation, the tetanic fade was significantly enhanced in the MET10 group compared to the other groups. This study shows that antagonists of muscarinic M 1 and M 2 receptors affect the rocuronium-induced neuromuscular block as demonstrated by the reduced EC 95 and TOF ratios (M 1 antagonist, pirenzepine) or the enhanced 50-Hz tetanic fade (M 2 antagonist, methoctramine).
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This study investigated the effect of muscarinic M 1 and M 2 receptor antagonists on [MET10]). The EC 95 of rocuronium was significantly lower in the PZP10 group than in the control group. In the PZP10 group, the TOF ratios at 50% and first twitch tension depression were significantly lower than those in the control group (P=.02). During tetanic stimulation, the tetanic fade was significantly enhanced in the MET10 group compared to the other groups. This study shows that antagonists of muscarinic M 1 and M 2 receptors affect the rocuronium-induced neuromuscular block as demonstrated by the reduced EC 95 and TOF ratios (M 1 antagonist, pirenzepine) or the enhanced 50-Hz tetanic fade (M 2 antagonist, methoctramine).
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| INTRODUCTION
Several types of receptors are found at neuromuscular presynaptic sites. 1,2 Some of these receptors function together to control the release of acetylcholine (ACh) during rest or stimulation. 2 For example, muscarinic and purinergic receptors interact at presynaptic neuronal sides. Of these receptors, muscarinic facilitatory M 1 and inhibitory M 2 receptors regulate the fine-tuning actions of ACh release on neuronal firing, and these receptors are in turn regulated by purinergic receptors. [3] [4] [5] [6] This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. y=50 + 50sin(Ωx), where y represents T1 depression, x represents the rocuronium concentration, and Ω represents the steepness of the curve. The Ω of PZP10 was larger than that of the control and PZP100 groups (P=.001 and .012, respectively) ( Figure 1C , Table 1 ).
The following equation was derived for TOFR: y=1 − λx 2 , where y represents the TOFR and x represents the rocuronium concentration. The λ of the PZP10 group was significantly larger than that of the other groups (P=.001) ( Figure 1D , Table 1 ), but no significant difference was observed between the Ω and λ values of the control and PZP100 groups (P=.39 for T1 depression, P=.83 for TOFR).
At T1-response depression of 50%, the TOF ratio was significantly lower in the PZP10 group than in the control group (0.251 ± 0.13 vs No significant differences were observed between the PZP100 group and either the control group or the PZP10 group. EC 50 and EC 95 were calculated using the concentration-response equation for each group in Figure 1A . The slope and intercept were calculated by linear regressions. The administered ROC values are expressed as mean (SE).
a Denotes values that were significantly lower than the results of other groups (P<.01).
0.364 ± 0.121; P=.02) ( Figure 2 ). However, no significant differences were found between the PZP100 group and the control group for any of the variables examined.
| Effect of muscarinic M 2 receptor blockade by MET on tetanic fade
A total of 30 phrenic nerve/hemidiaphragm tissue preparations were obtained, and each tissue specimen was randomly allocated to treatment with one of three concentrations of MET ( (Table 2) , but there were no significant differences between the groups. The last tetanic twitch tension depression (B values, illustrated in inset figure in Figure 4B ) and the , where y and x represent TOFR and concentration of rocuronium, respectively, and λ represents the slope of the regression curve. TOF fade was detected more rapidly in the PZP10 group than in the control (P=0.001). However, changes in these variables in the PZP100 group did not differ significantly from those observed in the other groups.
(A) (B) (C) (D)
F I G U R E 2 TOFR values at 40%-50% of T1 twitch tension depression. The TOFR value in the PZP10 group was significantly lower than that in the control group (*P=.02). However, the corresponding value in the PZP100 group did not differ significantly from that in the control or PZP10 groups change of the tetanic fade ratios became significant after the administration of rocuronium. The values during tetanic stimulation are shown in Table 2 .
When comparing the R value (which is the ratio of B over A) within the group, we found significant changes during the post-incubation period in all the groups in comparison with the initial R values within each group; however, only the post-incubation R values of the MET10 group were significantly lower than those of the control or MET1 groups (P=.005) ( Table 2 , Figure 3A) . The percentage changes in R values (%R=100×R post-incubation /R pre-incubation ) were larger in the MET10 group than in the other groups (P=.005) ( Figure 3B ).
| DISCUSSION
In this ex-vivo rat phrenic nerve/hemidiaphragm study, we found that presynaptic muscarinic cholinoreceptors play a role in modulating nerve-stimulated neuromuscular response, particularly during the administration of rocuronium. In particular, neuromuscular presynaptic M 1 receptors were found to play an important role in the rocuroniuminduced decrease in twitch tension and TOF fade. The EC 50 and EC 95
values of rocuronium and the TOFR at ~50% depression of the T1 were significantly lower in the PZP10 group than in the control group. These findings suggest that the facilitatory muscarinic M 1 receptor is functional when the phrenic nerve is subjected to TOF stimulation; however, the findings obtained from the PZP100 group did not suggest this.
Pirenzepine is generally used as a muscarinic M 1 -selective blocking agent because its affinity for M 1 receptors is ~200 times more than for M 2 receptors, 11 which indicates that it is not absolutely M 1 -specific.
Atropine acts as a non-specific muscarinic blocker to modulate ACh release by inhibiting both M 1 and M 2 receptors, which decreases spontaneous miniature end plate potential (mEPP) frequency and increases evoked ACh release. 2, 12 By modulating the spontaneous quantal release, presynaptic M 1 and M 2 receptors preserve and stabilize synaptic function. 12 TOF fade during neuromuscular blockade is a well-known presynaptic phenomenon that is primarily mediated by the nicotinic ACh receptor (nAChR). [13] [14] [15] [16] [17] [18] However, in an in-vivo rat study, it was found that the dihydro β erythroidine (DHβE)-induced blockade of the presynaptic α 3 β 2 nAChR did not cause any change in twitch tension or TOF fade. 19 We speculate that, in the PZP100 group, all these fac- . In the present study, the concentration of MET in the MET10 group was more than In conclusion, the overall function of neuromuscular presynaptic mAChRs is to preserve or save the presynaptic function in the presence of various neuronal stimulations. This function may be affected when the balance of action between these receptors is disrupted.
Moreover, we noted that presynaptic muscarinic M 1 receptors can modulate the rocuronium-induced EC 95 and TOF fade after PZP F I G U R E 3 (A) Comparison of the changes in the tetanic fade ratio after incubation with MET (R post-incubation /R pre-incubation ). During the initial and pre-incubation (Pre) periods, tetanic fade ratios did not significantly differ between the groups. However, the tetanic fade ratios in the post-incubation (Post) period in the MET10 group decreased more than in the other groups (*P=.005). (B) Comparison of the changes in the percentage of the tetanic fade ratio (%R) after incubation with MET (R post-incubation /R pre-incubation ). During the initial and pre-incubation periods, tetanic fade ratios did not significantly differ between the groups. However, the %R was significantly larger in the MET10 group than in the other groups (*P=.005) 
| METHODS

| Basic study design and sample preparation
The study protocol was approved before study initiation by the Ethics Sigma-Aldrich Korea (Gyeonggi Do, Republic of Korea). Two different PZP stock solutions and two different MET stock solutions were prepared and stored at 4°C in a refrigerator. These stock solutions were prepared such that the same volumes were used to achieve different concentrations of PZP or MET. The stock solutions were discarded 2 weeks after preparation. Subsequently, a 200 μg booster dose of rocuronium was added to the organ bath. We used a 10 min cycle until >95% depression of the T1 was achieved. The study protocol is illustrated in Figure 4A . The muscles were weighed after the experiments were complete. No significant inter-group differences were found. Results are presented as mean (SD). Length, length of the hemidiaphragm; Mwt, weight of the hemidiaphragm only; width, width of the hemidiaphragm; Wwt, weight of the diaphragm and adjacent tissues. Figure 4B ) was measured and calculated. As a final step, a rocuronium dose-response study was performed 30 min after the administration of the third tetanic stimulation. This study protocol is illustrated in Figure 4B .
| TOF fade study protocol
| Tetanic fade study protocol
| Statistical analysis
The primary end-point of this study was the concentration of rocuronium required to depress T1 by >95%. To achieve this goal, the rocuronium concentration was serially increased in Krebs buffer by repeatedly adding loading and booster doses of the drug at regular intervals while recording twitch tension. The second study end-point was the mean TOFR when T1 depression was in the range of 50%-60%. In the clinical setting, the recovery index (ie the period of T1
recovery from 25% to 75%) is useful for comparing recovery rates The group average TOFR value at the point where T1 twitch depression was in the range of 50%-60% was estimated and is expressed as a mean and standard deviation. Graphs were plotted and statistical analyses were completed using SPSS 13.0 software (SPSS Inc., 
